These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6679155)

  • 21. Commentary: infections in sickle cell and SC disease.
    Powars D; Overturf GD; Wilkins J
    J Pediatr; 1983 Aug; 103(2):242-4. PubMed ID: 6875716
    [No Abstract]   [Full Text] [Related]  

  • 22. Serotype-specific immunoglobulin G antibody responses to pneumococcal polysaccharide vaccine in children with sickle cell anemia: effects of continued penicillin prophylaxis.
    Bjornson AB; Falletta JM; Verter JI; Buchanan GR; Miller ST; Pegelow CH; Iyer RV; Johnstone HS; DeBaun MR; Wethers DL; Wang WC; Woods GM; Holbrook CT; Becton DL; Kinney TR; Reaman GH; Kalinyak K; Grossman NJ; Vichinsky E; Reid CD
    J Pediatr; 1996 Dec; 129(6):828-35. PubMed ID: 8969724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia.
    Weintrub PS; Schiffman G; Addiego JE; Matthay KK; Vichinsky E; Johnson R; Lubin B; Mentzer WC; Ammann AJ
    J Pediatr; 1984 Aug; 105(2):261-3. PubMed ID: 6747758
    [No Abstract]   [Full Text] [Related]  

  • 24. Antibody responses to polyvalent pneumococcal vaccine in infants with sickle cell anemia.
    Buchanan GR; Schiffman G
    J Pediatr; 1980 Feb; 96(2):264-6. PubMed ID: 7351592
    [No Abstract]   [Full Text] [Related]  

  • 25. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update: pneumococcal polysaccharide vaccine usage--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 May; 33(20):273-6, 281. PubMed ID: 6425629
    [No Abstract]   [Full Text] [Related]  

  • 27. Pneumococcal vaccines: World Health Organization position paper.
    Can Commun Dis Rep; 1999 Sep; 25(17):150-1. PubMed ID: 10513118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The assessment of pneumococcal vaccine.
    Austrian R
    N Engl J Med; 1980 Sep; 303(10):578-80. PubMed ID: 7402223
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal conjugate vaccine--prospects for intervention in children.
    Madhi SA; Klugman KP
    Semin Respir Infect; 1999 Sep; 14(3):285-94. PubMed ID: 10501316
    [No Abstract]   [Full Text] [Related]  

  • 30. Pneumococcal vaccine: a continuing controversy.
    Sims RV
    Hosp Pract (Off Ed); 1992 Apr; 27(4A):11, 14. PubMed ID: 1560082
    [No Abstract]   [Full Text] [Related]  

  • 31. Type-specific antibodies in children with sickle cell anemia given polyvalent pneumococcal vaccine.
    Kaplan J; Frost H; Sarnaik S; Schiffman G
    J Pediatr; 1982 Mar; 100(3):404-6. PubMed ID: 7062172
    [No Abstract]   [Full Text] [Related]  

  • 32. Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody.
    Overturf GD; Rigau-Perez JG; Selzer J; Field RJ; Powars D; Pang EJ; Uy C; Honig G; Weiss J; Chan L; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):19-23. PubMed ID: 7091573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization.
    Overturf GD; Selzer JW; Chan L; Weiss J; Field R; Rigau-Perez JG; Powars D; Uy C; Pang EJ; Honig G; Steele R; Edmonds R; Portnoy B
    Am J Pediatr Hematol Oncol; 1982; 4(1):25-35. PubMed ID: 7091574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study.
    Farr BM; Johnston BL; Cobb DK; Fisch MJ; Germanson TP; Adal KA; Anglim AM
    Arch Intern Med; 1995 Nov; 155(21):2336-40. PubMed ID: 7487259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility to invasive bacterial infections in children with sickle cell disease.
    Battersby AJ; Knox-Macaulay HH; Carrol ED
    Pediatr Blood Cancer; 2010 Sep; 55(3):401-6. PubMed ID: 20232448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
    Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
    Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug utilization.
    Pa Med; 1997 Nov; 100(11):36. PubMed ID: 9509878
    [No Abstract]   [Full Text] [Related]  

  • 38. Pneumococcal vaccine.
    Med Lett Drugs Ther; 1980 Dec; 22(26):114. PubMed ID: 7453667
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
    Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
    Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pneumococal vaccine in children].
    Sifontes JE
    Bol Asoc Med P R; 1979 Jul; 71(7):269-70. PubMed ID: 44476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.